Sevitex Tablet 5/40 mg
Olmesartan Medoxomil 40mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
International Pharmaceuticals Co., Ltd.
MFDS item code 201405095 · Approved 2014.10.31
This product's status changed to Expired on 2024.10.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement in blood pressure control for essential hypertension
This medication is used to effectively lower blood pressure in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using Amlodipine or Olmesartan Medoxomil. This helps to reduce the risk of cardiovascular disease and improves blood pressure control.
The recommended dosage is 1 tablet once daily, taken with water regardless of meals. It is advisable to take it at the same time every day (e.g., morning). The recommended dosages are as follows: - 5/20 mg: Administered to patients whose blood pressure is not adequately controlled with Amlodipine 5 mg or Olmesartan Medoxomil 20 mg monotherapy. - 10/20 mg: Administered to patients whose blood pressure is not adequately controlled with Olmesartan Medoxomil 20 mg monotherapy.
Safety and efficacy have not been established for pediatric patients under 18 years of age.
This drug can cause serious harm to the fetus and newborn if taken during the 2nd and 3rd trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Should not be used in patients with allergy to any component of this drug, those who are pregnant or breastfeeding, and in cases of severe liver impairment, aortic stenosis, bile duct obstruction, or renal dialysis. In patients with fluid or salt depletion, low blood pressure may occur at the start of treatment, so the patient's condition should be carefully monitored. Caution is especially required in severe aortic stenosis patients, as vascular dilation may lead to hypotension. Careful use is needed in patients with severe obstructive coronary artery disease or congestive heart failure, and monitoring for the exacerbation of heart failure is required. Changes in renal function may occur in patients with impaired renal function, therefore caution is needed. Patients with liver impairment may have a slower metabolism for the drug, hence caution is required. This medication may cause side effects such as dizziness, headache, hypotension, edema, nausea, rash, and if symptoms persist, consultation with a physician is recommended. Particularly, since blood potassium levels may rise, potassium supplements or potassium-sparing diuretics should be monitored periodically for blood potassium concentration when used together. The use of this drug should be avoided during pregnancy, and if there are plans for pregnancy or if pregnancy is confirmed, consulting with a doctor is mandatory. In nursing mothers, as this drug can be transmitted through breast milk, it is recommended to either stop breastfeeding or discontinue the medication. Safety and efficacy in children under 18 years of age have not been established, so it is not recommended. Elderly patients over the age of 65 should start from a low dose, considering renal and liver function, and closely monitor their condition. Overdose may cause symptoms such as hypotension and tachycardia, requiring immediate medical attention.
Hives, angioedema, acute renal failure, increased serum creatinine, autoimmune hepatitis, jaundice, elevated liver enzymes, leukopenia, thrombocytopenia, toxic epidermal necrolysis, severe dizziness (one of the serious adverse events), exacerbation of cerebral infarction, gum bleeding (one of the serious adverse events)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius.
Pale yellow round film-coated tablet
30 tablets / box [(10 tablets / PTP × 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 40mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
International Pharmaceuticals Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.